Wow - some PR - precision targeted like his biomarker patents!
Watch out - once Abbott and/or Quest come out with their findings - full speed ahead! Watch him go after ACS and change their tune regarding PSA test's accuracy.
Again, continue to accumulate on dips. Think about it - what IF the stock jumps to $2 --- does it matter if you bought it at .20 or .25 or .30. Go figure!
Market Data 
Markets 
AI
